The Drug Enforcement Administration (DEA) released a temporary rule extending COVID-era telehealth flexibilities from the end of the public health emergency (PHE) on May 11 to Nov. 11, 2023. The extension allows clinicians prescribing controlled substances over telehealth to continue to do so for another six months. Patients that initiate care on or before Nov. […]
The Drug Enforcement Administration confirmed that it will extend COVID-era telehealth flexibilities. On Wednesday, the agency said it needs additional time to work through the mountain of comments it received on two rules that would claw back telehealth and controlled substance prescribing flexibilities. “We take those comments seriously and are considering them carefully,” DEA Administrator […]
The Drug Enforcement Administration appears to have filed for a temporary extension of telehealth flexibilities beyond the public health emergency. This reflects an apparent reaction on the part of the DEA to the major backlash it faced during the public comment period for two rules it release that would reestablish austere restrictions on accessing treatment […]
The proposed telehealth-prescribing rules from the Drug Enforcement Administration (DEA) could require digital addiction providers to fundamentally change their business model and limit patient access to virtual addiction treatment. These new rules will likely hit patients with the least access to status quo treatment models the hardest, especially for access to medication-assisted treatment (MAT). “Roughly […]
The two proposed rules from the Drug Enforcement Administration (DEA) that effectively undue controlled substances prescribing via telehealth have received over 21,000 submissions so far during its public comment period. And the overwhelming majority of those comments oppose the proposed rules as presented. The DEA released the proposed rules on Feb. 24. The proposed rules […]
After years of waiting, the Drug Enforcement Administration (DEA) on Friday rolled out a new proposal to better formalize controlled substance prescriptions via telehealth. However, the proposal is not the long-awaited registration process Congress mandated for addiction treatment. If finalized, DEA’s proposed plan also moves some aspects of telehealth prescribing back to a pre-public health […]
Forty-five state attorneys general have signed a letter asking the federal government to preserve COVID-era regulations for virtual addiction treatment. The letter, which was organized by the National Association of Attorneys General (NAAG), was sent to the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA). The letter specifically calls on […]
The virtual ADHD medication management company Done Global Inc., branded as Done., is reportedly under investigation by the Drug Enforcement Administration’s Diversion Control Division. DEA diversion control division agents have also made similar inquiries to Cerebral Inc., a virtual mental health company that promised speedy access to mental health prescribers, according to a Wall Street […]
Facility-based behavioral health operators may be better positioned to cope with changing telehealth regulations than their virtual-only peers. That’s because facility operators who use telehealth have the required building blocks to apply in-person treatment or telehealth as needs arise. In contrast, virtual-only companies must find other ways to partner or integrate with facility operators, according […]
The scrutiny around mental health startup Cerebral Inc. following the company’s meteoric rise and subsequent criticism has generated new challenges for the company. A House committee has launched a review of how the Drug Enforcement Administration (DEA) has enforced the Ryan Haight Act, which dictates how controlled substances are allowed to be prescribed via telehealth. […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
